TCRX 8-K 2026-09-30

TScan Therapeutics, Inc. (TCRX) 8-K dated 2026-09-30 — accession 0001193125-26-409199. This URL is the filing, not the TCRX hub.

TScan Therapeutics, Inc. (TCRX) is a biotechnology company listed on NASDAQ.

TScan Therapeutics, Inc. filed a 8-K on 2026-09-30. Accession 0001193125-26-409199.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TCRX revenue for 2025-12-31 was $10.3M. Net income was -$129.8M. Revenue was up 266.7% from 2024-12-31 to 2025-12-31. TCRX currently screens at market cap $62.1M.

Not investment advice. The TCRX SEC hub lists recent forms. The stock page is the research view.